Mohd H. Abdul‐Aziz

Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis

Mohd H. Abdul‐Aziz, Helmi Sulaiman, Mohd Basri Mat Nor et al. · Intensive Care Medicine · 2016 · 310 citations

Critical Care Medicine, Severe Sepsis, Controlled Trial +8

Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort

Mohd H. Abdul‐Aziz, Jeffrey Lipman, Murat Akova et al. · Journal of Antimicrobial Chemotherapy · 2015 · 157 citations · Full text

Continuous beta-lactam infusion in critically ill patients: the clinical evidence

Mohd H. Abdul‐Aziz, Joel M. Dulhunty, Rinaldo Bellomo et al. · Annals of Intensive Care · 2012 · 113 citations · Full text

Pharmacotherapy, Drug Resistance, Continuous Beta-lactam Infusion +19

Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics.

Mohd H. Abdul‐Aziz, Christine E. Staatz, Carl M. J. Kirkpatrick et al. · PubMed · 2012 · 59 citations

Therapeutic Drug Monitoring, Antimicrobial Stewardship, Antibiotics +13

What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?

Abdulaziz S. Alobaid, Alexander Brinkmann, Otto Frey et al. · Journal of Antimicrobial Chemotherapy · 2015 · 56 citations · Full text